Replimune Group, Inc. (REPL) Social Stream
REPLIMUNE GROUP INC (REPL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering REPL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $64 | $49 | $56 | $8.81 | 535.64% |
| 2021-11-15 | 7 | $64 | $49 | $55.857 | $8.81 | 534.02% |
| 2022-02-03 | 8 | $64 | $49 | $55.375 | $8.81 | 528.55% |
| 2022-02-07 | 8 | $64 | $42 | $54.125 | $8.81 | 514.36% |
| 2022-03-30 | 8 | $60 | $42 | $52.25 | $8.81 | 493.08% |
| 2022-05-19 | 8 | $60 | $39 | $51.25 | $8.81 | 481.73% |
| 2022-05-24 | 8 | $60 | $36 | $49.75 | $8.81 | 464.7% |
| 2022-08-04 | 8 | $60 | $36 | $48.875 | $8.81 | 454.77% |
| 2022-08-17 | 8 | $60 | $36 | $47.5 | $8.81 | 439.16% |
| 2022-08-29 | 8 | $60 | $33 | $47 | $8.81 | 433.48% |
| 2022-10-03 | 8 | $60 | $30 | $46.125 | $8.81 | 423.55% |
| 2022-11-03 | 8 | $60 | $30 | $43.625 | $8.81 | 395.18% |
| 2022-11-04 | 8 | $52 | $33 | $42.5 | $8.81 | 382.41% |
| 2022-11-08 | 8 | $52 | $33 | $42.625 | $8.81 | 383.83% |
| 2022-12-08 | 8 | $52 | $34 | $42.75 | $8.81 | 385.24% |
| 2022-12-12 | 8 | $70 | $34 | $46.5 | $8.81 | 427.81% |
| 2022-12-14 | 8 | $70 | $34 | $48.375 | $8.81 | 449.09% |
| 2023-01-05 | 9 | $70 | $34 | $49.666 | $8.81 | 463.75% |
| 2023-02-10 | 8 | $70 | $34 | $50.625 | $8.81 | 474.63% |
| 2023-02-23 | 8 | $70 | $34 | $51.375 | $8.81 | 483.14% |
| 2023-04-17 | 8 | $70 | $34 | $49.625 | $8.81 | 463.28% |
| 2023-05-22 | 8 | $70 | $33 | $49.5 | $8.81 | 461.86% |
| 2023-06-08 | 8 | $70 | $33 | $49.625 | $8.81 | 463.28% |
| 2023-08-04 | 8 | $70 | $33 | $51.125 | $8.81 | 480.31% |
| 2023-08-07 | 8 | $70 | $33 | $50.125 | $8.81 | 468.96% |
| 2023-11-08 | 8 | $70 | $33 | $49.125 | $8.81 | 457.6% |
| 2023-11-13 | 8 | $70 | $32 | $48.75 | $8.81 | 453.35% |
| 2023-11-24 | 8 | $70 | $32 | $48.25 | $8.81 | 447.67% |
| 2023-12-06 | 10 | $60 | $10 | $21.5 | $8.81 | 144.04% |
| 2023-12-08 | 10 | $60 | $10 | $17.7 | $8.81 | 100.91% |
The Trend in the Analyst Price Target
REPL's average price target has moved down $36.42 over the prior 22 months.
REPL reports an average of 175.73% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-23 | 8 | 70 | 34 | 51.375 | 22.32 | 130.17% |
| 2023-06-15 | 8 | 70 | 33 | 51.125 | 24.02 | 112.84% |
| 2023-08-07 | 8 | 70 | 33 | 50.125 | 18.95 | 164.51% |
| 2023-08-16 | 8 | 70 | 33 | 49.125 | 18.80 | 161.3% |
| 2023-09-29 | 8 | 70 | 33 | 49.125 | 17.11 | 187.11% |
REPL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
REPL's average broker recommendation rating improved by 0 over the prior 16 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how REPLIMUNE GROUP INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 3693.16% of that group.
- In terms of how REPLIMUNE GROUP INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2545.88% of that group.
- REPLIMUNE GROUP INC's average analyst price target is higher than 2631.85% of Pharmaceutical Products stocks.
- REPL has a greater number of analysts covering the stock than 2231.6% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, KRYS, MESO, and PLX are the three stocks most similar to REPLIMUNE GROUP INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is REPL a Buy, Hold or Sell? See the POWR Ratings now!